Sheel Bio.

Why is Sheel Biotech Ltd falling/rising?

As of 01-Sep, Sheel Biotech Ltd's stock price is stable at 61.65, with a recent short-term gain of 4.94% but a significant decline of 9.34% over the past month. The decrease in trading volume suggests waning investor interest, contributing to the stock's current price stability.

As of 01-Sep, Sheel Biotech Ltd's stock price is currently stable at 61.65, showing no change (0.00%). However, the stock has experienced a mixed performance over different periods. In the past week, it has risen by 4.94%, outperforming the Sensex, which fell by 1.15%. This short-term gain suggests some positive momentum. <BR><BR>In contrast, the stock has declined by 9.34% over the past month, while the Sensex has only decreased by 1.34%. This indicates a more significant downturn in the stock's performance relative to the broader market over a longer timeframe. Additionally, year-to-date performance data is not available, but the stock has not shown strong performance over the past year, with no data provided for that period.<BR><BR>Today's trading activity indicates a decline in investor participation, with a delivery volume of 4,000 shares on August 31, which is a 50% drop compared to the 5-day average. This decrease in trading volume could suggest waning interest among investors, which may contribute to the stock's price stability at this level.<BR><BR>Overall, while the stock has shown some short-term gains, the longer-term decline and reduced investor participation may be factors contributing to its current price stability.

What does Sheel Bio. do?

Sheel Biotech Ltd operates in the Other Agricultural Products industry as a Micro Cap company with a market cap of INR 120 Cr. Key metrics include a P/E ratio of 11.00, a debt-equity ratio of 0.32, and a return on equity of 13.99%.

Overview: <BR>Sheel Biotech Ltd operates in the Other Agricultural Products industry and is classified as a Micro Cap company.<BR><BR>History: <BR>The incorporation year and any status changes are not available. The latest quarter for which sales and profit are reported is also not available.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: N/A <BR>Most recent Net Profit: N/A <BR>Market-cap value: INR 120 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 11.00 <BR>Industry P/E: 43 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: 0.32 <BR>Return on Equity: 13.99% <BR>Price-to-Book: 1.42<BR><BR>Contact Details: <BR>Registrar Address: Not available <BR>Phone: Not available <BR>Email: Not available <BR>Website: Not available

Who are the peers of the Sheel Bio.?

Sheel Bio.'s peers include Kohinoor Foods, Shreeoswal Seeds, Upsurge Seeds, Puretrop Fruits, Nag. Agri Tech., JK Agri Genetics, Naturite Agro, Harshdeep Horti., and MANGALAM SEEDS. Kohinoor Foods has the highest 1-year return at -0.26%, while Upsurge Seeds has the lowest at -48.07%.

Peers: The peers of Sheel Bio. are Kohinoor Foods, Shreeoswal Seeds, Upsurge Seeds, Puretrop Fruits, Nag. Agri Tech., JK Agri Genetics, Naturite Agro, Harshdeep Horti., and MANGALAM SEEDS.<BR><BR>Quality Snapshot: Excellent management risk is observed at Harshdeep Horti., while Average management risk is found at JK Agri Genetics and MANGALAM SEEDS, and the rest have Below Average management risk. Good growth is noted at Shreeoswal Seeds, Upsurge Seeds, Nag. Agri Tech., Harshdeep Horti., and MANGALAM SEEDS, while the rest have Below Average growth. Good capital structure is seen at Puretrop Fruits and Nag. Agri Tech., Average capital structure is found at MANGALAM SEEDS and JK Agri Genetics, and the rest have Below Average capital structure.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Kohinoor Foods at -0.26%, while Upsurge Seeds has the lowest at -48.07%. Sheel Bio.'s 1-year return is not available for comparison. Additionally, peers with negative six-month returns include Upsurge Seeds and Shreeoswal Seeds.

How big is Sheel Bio.?

As of 31st August, Sheel Biotech Ltd has a market capitalization of 120.00 Cr, classified as a Micro Cap, with no valid financial data available for Net Sales and Net Profit for the latest four quarters. The balance sheet as of March 2025 shows Shareholder's Funds of 83.85 Cr and Total Assets of 113.23 Cr.

As of 31st August, <BR><BR>Market Cap: Sheel Biotech Ltd has a market capitalization of 120.00 Cr and is classified as a Micro Cap.<BR><BR>Recent Quarterly Performance: There is no valid financial data available for Net Sales and Net Profit for the latest four quarters.<BR><BR>Balance Sheet Snapshot: The reporting period is March 2025, with Shareholder's Funds amounting to 83.85 Cr and Total Assets totaling 113.23 Cr.

Which are the latest news on Sheel Bio.?